Seehra Jasbir 4
4 · Keros Therapeutics, Inc. · Filed Jun 10, 2022
Insider Transaction Report
Form 4
Seehra Jasbir
DirectorCHIEF EXECUTIVE OFFICER
Transactions
- Exercise/Conversion
Employee Stock Option (right to buy)
2022-06-09−5,000→ 8,822 totalExercise: $0.30Exp: 2028-03-25→ Common Stock (5,000 underlying) - Exercise/Conversion
Common Stock
2022-06-09$0.30/sh+5,000$1,500→ 248,856 total
Footnotes (1)
- [F1]Fully vested and exercisable.